| Page 901 | Kisaco Research

Jocelyn Ashford

The Health Equity in Clinical Trials Congress was the most productive and actionable meeting on the topic that I’ve attended. Not only was I able to hear tangible, real life successes and failures; but I had the opportunity to pick the brains of some of the brightest in the space in Industry.

Mesha Martinez

Very informative conference from great minds and group enthusiastic about helping to make the world a better place and advancing health equity. 

Margarita Nunez MD

I felt privileged to be part of this conversation and to hear from and meet such an accomplished group of people.

Sarah Friedhoff

Fantastic speakers who were able to illuminate tangible things we can be doing *NOW* to make a difference, as well as sharing the path ahead.

Leigh Boehmer

It was so energizing being amongst the health equity thought and practice leaders from across the globe! 

Wanda Hill

By far one of the best congresses I have attended on this topic. The insights gained from each session were valuable. 

LaShell Robinson

The inaugural Health Equity Congress brought colleagues from across the industry together for the first time. It was wonderful to hear successes, best practices and how we could all continue to work together.  

 

Mike Walsh

National Security Lawyer and Partner
Shearman & Sterling

Mike Walsh is a national security lawyer and partner in Shearman & Sterling’s Litigation practice. A former chief of staff and acting GC at the U.S. Department of Commerce, Mike represents companies and venture capital funds on cross-border investment issues at the intersection of trade and national security, including CFIUS, export controls, Department of Commerce Entity Listings, OFAC sanctions, ITAR and DDTC requirements, and anti-money laundering compliance, and forced labor compliance.

Mike Walsh

National Security Lawyer and Partner
Shearman & Sterling

Mike Walsh

National Security Lawyer and Partner
Shearman & Sterling

Mike Walsh is a national security lawyer and partner in Shearman & Sterling’s Litigation practice. A former chief of staff and acting GC at the U.S. Department of Commerce, Mike represents companies and venture capital funds on cross-border investment issues at the intersection of trade and national security, including CFIUS, export controls, Department of Commerce Entity Listings, OFAC sanctions, ITAR and DDTC requirements, and anti-money laundering compliance, and forced labor compliance. Mike also counsels multinational companies, officers, and directors on economic, legal, and compliance issues related to geopolitical risk management.